Last reviewed · How we verify

NCT07253844: TrA RA IRD DRA

Effects of Transverse Abdominis Activation and Rectus Abdominis Strengthening on Inter-rectus Distance and Core Stability

Not yet recruiting NA Last updated 28 November 2025
What this trial tests

NA trial testing Transverse Abdominis activation exercises in Diastasis Recti Abdominis (DRA) in 33 participants. Not yet recruiting.

Timeline
25 November 2025
Primary endpoint
25 May 2026
30 May 2026

Quick facts

Lead sponsorLahore University of Biological and Applied Sciences
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment33
Start date25 November 2025
Primary completion25 May 2026
Estimated completion30 May 2026
Sites2 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Lahore University of Biological and Applied Sciences

Who can join

Adults 20 to 40, female only, with Diastasis Recti Abdominis (DRA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to compare the effects of Transverse Abdominis (TrA) activation, Rectus Abdominis (RA) strengthening, and their combined approach on inter-rectus distance (IRD) and core stability in postpartum women diagnosed with diastasis rectus abdominis (DRA). Thirty-three participants will be randomly allocated into three groups and will complete a six-week exercise program at the Pakistan Society for the Rehabilitation of the Disabled (PSRD) Hospital, Lahore. The study will use real-time ultrasound and pressure biofeedback assessment to evaluate changes in IRD and core stability. It is hypothesized that TrA activation and the combined intervention will produce greater improvements compared to RA strengthening alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diastasis Recti Abdominis (DRA)

Currently open trials in the same condition.

Other Lahore University of Biological and Applied Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07253844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing